-+ 0.00%
-+ 0.00%
-+ 0.00%

CanSinoBIO, deepGeneAI sign framework pact to develop personalized mRNA cancer vaccines

PUBT·08/25/2026 09:01:51
Listen to the news
CanSinoBIO, deepGeneAI sign framework pact to develop personalized mRNA cancer vaccines
  • CanSino Biologics unit CanSino Shanghai signed a strategic cooperation framework with deepGeneAI to jointly develop personalized mRNA cancer vaccines.
  • Parties plan to target global markets, focusing on gastrointestinal solid tumors plus rare tumors, spanning research, clinical translation, submissions, commercialization.
  • CanSino Shanghai to provide mRNA delivery, formulation, R&D, manufacturing; deepGeneAI to supply AI-driven neoantigen prediction, screening, sequence design.
  • Collaboration centers on CanSino’s mRNA platform, including its ISL-3C-LNP lipid nanoparticle delivery system based on proprietary ionizable sterol lipid.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cansino Biologics Inc. published the original content used to generate this news brief on August 25, 2026, and is solely responsible for the information contained therein.